The FDA has labeled a recall of 28,882 HeartMate II System controllers initiated by Abbott Laboratories as Class I following reports of 70 malfunction incidents and 26 deaths after patients replaced their units at home. "We are updating its alert guides, conducting a software upgrade and adding controller alignment markings for the HeartMate II System Controller as part of a continued effort to ensure patients are successfully able to exchange their pocket controller in emergency situations," said Abbott spokesman Justin Paquette.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information
that is changing your industry today, hand-curated by our professional editors from
thousands of sources and delivered straight to your inbox.